Barclays Initiates Coverage On Omada Health with Overweight Rating, Announces Price Target of $21

Benzinga · 07/01 11:58
Barclays analyst Saket Kalia initiates coverage on Omada Health (NASDAQ:OMDA) with a Overweight rating and announces Price Target of $21.